Alterity Therapeutics Ltd. (PRNAF)
OTHER OTC:PRNAF
Holding PRNAF?
Track your performance easily

Alterity Therapeutics Ltd. (PRNAF) Income Statement

3 Followers

Alterity Therapeutics Ltd. Income Statement

Last quarter (Q ), Alterity Therapeutics Ltd.'s total revenue was AU$―, a decrease of ― from the same quarter last year. In Q, Alterity Therapeutics Ltd.'s net income was AU$―. See Alterity Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
--AU$ 3.93M-AU$ 0.00AU$ 0.00
Cost of Revenue
------
Gross Profit
--AU$ 3.93M---
Operating Expense
-AU$ 23.63MAU$ 14.35MAU$ 20.26MAU$ 14.74MAU$ 13.47M
Operating Income
-AU$ -23.63MAU$ -14.64MAU$ -20.26MAU$ -14.74MAU$ -13.47M
Net Non Operating Interest Income Expense
-AU$ 268.42KAU$ 16.44KAU$ 2.50KAU$ 20.68KAU$ 17.12K
Other Income Expense
-AU$ -4.02MAU$ 651.84KAU$ -4.76MAU$ -591.34KAU$ -7.85K
Pretax Income
-AU$ -19.08MAU$ -13.70MAU$ -12.78MAU$ -15.31MAU$ -13.46M
Tax Provision
-AU$ 46.09KAU$ 104.46KAU$ 70.01KAU$ 0.00AU$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-AU$ -19.12MAU$ -13.81MAU$ -12.85MAU$ -15.31MAU$ -13.46M
Basic EPS
-AU$ -0.52AU$ -0.01---
Diluted EPS
-AU$ -0.52AU$ -0.01---
Basic Average Shares
-AU$ 3.65BAU$ 2.43B---
Diluted Average Shares
-AU$ 3.65BAU$ 2.43B---
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----AU$ 87.61KAU$ 72.76K
Total Expenses
-AU$ 23.63MAU$ 14.35MAU$ 20.26MAU$ 14.74MAU$ 13.47M
Net Income From Continuing And Discontinued Operation
-AU$ -19.12MAU$ -13.81MAU$ -12.85MAU$ -15.31MAU$ -13.46M
Normalized Income
-AU$ -18.89M--AU$ -15.08MAU$ -13.80M
Interest Expense
------
EBIT
-AU$ -19.08M-AU$ -12.78MAU$ -14.74MAU$ -13.47M
EBITDA
-AU$ -18.93M-AU$ -12.78MAU$ -14.66MAU$ -13.35M
Currency in AUD

Alterity Therapeutics Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis